RxDoctor Payments Data

Adebayo Akinsola

Pediatrics · Chamblee, GANPI 1407086879

Payments from drug & device makers

What this record shows

Modernatx, Inc. accounts for 88.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,631 and has fallen 94.6% since, to $141 in 2025. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,959in general payments, 2019–2025

Across 26 payments — averaging $113.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3K
  • Sanofi Pasteur Inc.$119
  • Merck$89
  • GSK$52
  • Cranial Technologies, Inc$45
  • Pfizer$22
$6,392,324in research payments, 2019–2025

Across 2,239 payments — averaging $2854.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$4.3M
  • Pfizer$588K
  • Bavarian Nordic A/s$505K
  • Sanofi Pasteur Inc.$315K
  • GSK$309K
  • Novavax Inc$145K
  • plus $209K from 4 others

What the payments were for

  • Travel & lodging$1,74559%
  • Food & beverage$1,21441%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,959 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia

Other pediatrics in Chamblee

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →